FREE DOMESTIC SHIPPING OVER $33.00
A cross-over, pharmacokinetic pilot study (single oral dose) in humans compared a typical ubiquinol preparation to ubiquinol in the VESIsorb delivery system and demonstrated a 696% increase in peak blood levels (Cmax) and a 485% increase in relative bioavailability (AUC(0-24 hr)).
A clinical study of CoQ10 with the VESIsorb delivery system indicates a peak absorption of 16.97% compared to reported peak absorption of CoQ10 powder, an oil dispersion, and a lipid solution which were at 2.15%, 3.34% and 5.44% respectively.
The VESIsorb delivery system enhanced CoQ10 bioavailability by 622% compared to oil-based CoQ10 and 499% compared to solubilized CoQ10.
Ubiquinol is the active antioxidant form of CoQ10, the preferred form for individuals over 40 or those experiencing increased oxidative stress
[ITEMPRICE]